Corpus Intelligence Market Analysis — HARLINGEN MEDICAL CENTER 2026-04-26 12:34 UTC
Market Analysis — HARLINGEN MEDICAL CENTER
TX market | 8 hospitals | HHI: 2,506 (Concentrated)
🛡️ Public data only — no PHI permitted on this instance.
8
Hospitals in Market
1,180
Total Beds
$1.0B
Market Revenue
Concentrated
HHI: 2,506
None
Moat Rating (2/10)
#4
Market Share Rank

Competitive Moat (Mauboussin Framework)

Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).

Scale Advantageweak
Switching Costsmoderate
Market Share11.1%
Top 3 Concentration79.6%
Network Density0.68
Margin vs Market-9.1%
Bed Util vs Market+4.8%

What This Means

This hospital has a none moat — no moat — commoditized market position, pricing power limited. The TX market is highly concentrated — few dominant players, potential antitrust concerns (HHI: 2,506).

Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full TX market.

Top Competitors

HospitalBedsRevenueRev ShareBed Share
VALLEY BAPTIST MEDICAL CENTER348$395M39.3%29.5%
VALLEY REGIONAL MEDICAL CENTER187$203M20.2%15.8%
VALLEY BAPTIST MED CNTR BROWNSVILLE240$202M20.1%20.3%
SOLARA SPECIALTY HARLINGEN82$46M4.5%7.0%
RIO GRANDE STATE CENTER77$18M1.8%6.5%
SOUTH TEXAS REHABILITATION HOSPITAL40$17M1.7%3.4%
PALMS BEHAVIORAL HEALTH94$13M1.3%8.0%

Regional Payer Mix

■ Medicare 18%■ Medicaid 5%■ Commercial 76%